44 related articles for article (PubMed ID: 19303673)
1. Teriparatide therapy for medication-related osteonecrosis of the jaw: case report and literature review.
Mohamed MM; Gunasekera WM; Glew D; Bell C; Bhalla AK
Clin Med (Lond); 2022 Jul; 22(Suppl 4):20-21. PubMed ID: 36220254
[No Abstract] [Full Text] [Related]
2. Necrotizing Fasciitis with Medication-related Osteonecrosis of the Jaw.
Ishibashi H; Sasahara T; Katagiri O; Yamada T
Intern Med; 2024 Mar; 63(6):887-888. PubMed ID: 37532542
[No Abstract] [Full Text] [Related]
3. Authors' reply: Medication-related osteonecrosis of the jaw in osteoporotic patients: prevention and management.
Chan BH; Yee R; Puvanendran R; Ang SB
Singapore Med J; 2018 May; 59(5):288. PubMed ID: 29796683
[No Abstract] [Full Text] [Related]
4. Treating osteoporosis: do bisphosphonates really increase the risk of osteonecrosis of the jaw?
Thompson E; Sheehy C; Barry M; Carey J
Ir Med J; 2008 Jun; 101(6):166-7. PubMed ID: 18700507
[No Abstract] [Full Text] [Related]
5. Association between bisphosphonates and jaw osteonecrosis: a study in Wistar rats.
Maahs MP; Azambuja AA; Campos MM; Salum FG; Cherubini K
Head Neck; 2011 Feb; 33(2):199-207. PubMed ID: 20848442
[TBL] [Abstract][Full Text] [Related]
6. [Osteonecrosis of the jaw].
Pierrot-Deseilligny Despujol C; Pouchot J
Rev Med Interne; 2009 Aug; 30(8):706-7. PubMed ID: 19482388
[No Abstract] [Full Text] [Related]
7. Jaw osteonecrosis in patients treated with bisphosphonates: an ultrastructural study.
Perrotta I; Cristofaro MG; Amantea M; Russo E; De Fazio S; Zuccalà V; Conforti F; Amorosi A; Donato G; Tripepi S; Giudice M
Ultrastruct Pathol; 2010 Aug; 34(4):207-13. PubMed ID: 20594040
[TBL] [Abstract][Full Text] [Related]
8. [Osteonecrosis of the jaw and bisphosphonates: current data and perspectives].
Gligorov J; Launay-Vacher V; Debrix I
Rev Med Interne; 2009 Aug; 30(8):653-5. PubMed ID: 19303673
[No Abstract] [Full Text] [Related]
9. Osteonecrosis of the jaw related to the use of bisphosphonates.
Van den Wyngaert T; Huizing MT; Vermorken JB
Curr Opin Oncol; 2007 Jul; 19(4):315-22. PubMed ID: 17545793
[TBL] [Abstract][Full Text] [Related]
10. Oral bisphosphonates and osteonecrosis of the jaw.
Wynn RL
Gen Dent; 2007; 55(1):8-10. PubMed ID: 17333956
[No Abstract] [Full Text] [Related]
11. Bisphosphonates, hypercalcemia of malignancy, and osteonecrosis of the jaw.
Wynn RL
Gen Dent; 2005; 53(6):392-5. PubMed ID: 16366043
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
